Women with low testosterone

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

In Campbell’s mind, though, it comes down to choice. Since she wasn’t part of the flibanserin clinical trials, “I don’t even know if it would work for me. But I’d love for it to be approved so I can try it, and see if it works.”  But even if flibanserin gets rejected once again—or even if it gets approved and Campbell (who was introduced to me by the drug manufacturer) finds that it isn’t the cure-all she was hoping for—there’s been one positive outcome: The debate over FDA approval has created a more open conversation about female sexual dysfunction.

Women with low testosterone

women with low testosterone


women with low testosteronewomen with low testosteronewomen with low testosteronewomen with low testosteronewomen with low testosterone